(New York, NY - November 21, 2023) – Mount Sinai Health System announced that Brendan Carr, MD, MA, MS, a nationally recognized leader in academic medicine and health policy, will be its next Chief Executive Officer.
Dr. Carr joined Mount Sinai as its head of emergency medicine in February 2020, just before New York City became the initial epicenter of the COVID-19 pandemic in the United States. He played a critical role during the pandemic and led local, regional, and national initiatives focused on improving the Health System’s emergency and critical care capacity. He was chosen after a nationwide search.
Kenneth L. Davis, MD, a transformative leader who has been Chief Executive Officer of the Health System and its predecessor since 2003, will become Executive Vice Chairman of the Mount Sinai Boards of Trustees. Both appointments are effective early next year.

Ad Statistics
Times Displayed: 118236
Times Visited: 6879 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
“Dr. Carr is a visionary leader and physician who will chart an exciting course for the Health System,” said Richard A. Friedman and James S. Tisch, Co-Chairmen of the Boards of Trustees of the Mount Sinai Health System. “We are certain that he will propel Mount Sinai to further success in our mission to provide compassionate patient care through unrivaled education, research, and outreach in the many diverse communities we serve.”
Mr. Friedman and Mr. Tisch added: “We want to once again thank Dr. Davis for his remarkable and transformative tenure leading Mount Sinai for more than 20 years, and are delighted that we will continue to benefit from his wisdom in his new role. We are extremely fortunate and grateful for Ken’s service and equally excited and honored to have a physician-executive as qualified and accomplished as Dr. Carr as the system’s next leader.”
As Chief Executive Officer, Dr. Carr will report to the Boards of Trustees. In partnership with them, he will chart a strategy for Mount Sinai’s next chapter, and will oversee all critical strategic, operational, and business-building areas of the Health System, including its eight hospitals, the Icahn School of Medicine at Mount Sinai, and more than 400 ambulatory locations and physician practices.
"I am honored and deeply grateful for the opportunity to lead this preeminent institution and dynamic team of people who care deeply about advancing health for the patients and communities we serve,” Dr. Carr said. “Together, we will continue to innovate in order to provide the safe, high-quality, and equitable care that our patients deserve and expect. I would also like to recognize Dr. Davis for his tremendous accomplishments and thank Jim and Rich for their support and partnership.”